Valeant Pharmaceuticals International, Inc. - Mergers and Acquisitions (M&A), Partnerships and Alliances and Investment Report

Valeant Pharmaceuticals International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketlines Valeant Pharmaceuticals International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Valeant Pharmaceuticals International, Inc. since January 2007.

synopsis

Marketlines Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Valeant Pharmaceuticals International, Inc.s contact information and business Summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Valeant Pharmaceuticals International, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Valeant Pharmaceuticals International, Inc.s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Valeant Pharmaceuticals International, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Valeant Pharmaceuticals International, Inc.s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Valeant Pharmaceuticals International, Inc.s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors business structure and growth strategies.

COMPANY OVERVIEW AND KEY FACTS 2



TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions - Overview 8
Mergers and Acquisitions - Deal reports 9
PARTNERSHIP 133
Partnership - Overview 133
Partnership - Deal reports 134
CAPITAL RAISING 299
Capital Raising - Deal reports 299
DIVESTMENTS 310
Divestments - Overview 310
Divestments - Deal reports 311
PRIVATE EQUITY & OWNERSHIP 324
Private Equity and Ownership - Deal reports 324
APPENDIX 328
Contact Us 328
About MarketLine Financial Deals Database 328
Deal Definition and Methodology 330
About MarketLine 337

List Of Tables

List of Tables
Table 1: Valeant Pharmaceuticals International M&A volume and value trend (2014-YTD2018)
Table 2: Valeant Pharmaceuticals International M&A activity by geography (2014-YTD2018)
Table 3: Valeant Pharmaceuticals International partnership volume and value trend (2014-YTD2018)
Table 4: Valeant Pharmaceuticals International partnership trend by key deal type (2014-YTD2018)
Table 5: Valeant Pharmaceuticals International divestments volume and value trend (2014-YTD2018)
Table 6: Valeant Pharmaceuticals International divestments activity by geography (2014-YTD2018)

List Of Figures

List of Figures
Figure 1: Valeant Pharmaceuticals International M&A volume and value trend (2014-YTD2018)
Figure 2: Valeant Pharmaceuticals International M&A activity by geography (2014-YTD2018)
Figure 3: Valeant Pharmaceuticals International partnership volume and value trend (2014-YTD2018)
Figure 4: Valeant Pharmaceuticals International partnership trend by key deal type (2014-YTD2018)
Figure 5: Valeant Pharmaceuticals International divestments volume and value trend (2014-YTD2018)
Figure 6: Valeant Pharmaceuticals International divestments by geography (2014-YTD2018)

2019 Pharmaceutical Competitive Intelligence: Valeant Pharmaceuticals Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization

USD 950 View Report

2018 Pharmaceutical Competitive Intelligence: Valeant Pharmaceuticals Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization and

USD 950 View Report

2019 Pharmaceutical Competitive Intelligence: Valeant Pharmaceuticals Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization

USD 950 View Report

2018 Pharmaceutical Competitive Intelligence: Valeant Pharmaceuticals Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization and

USD 950 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available